Will Tauzin spice up PhRMA?
Executive Summary
Rep. Billy Tauzin (R-La.) moves to top of list of candidates to succeed retiring Pharmaceutical Research & Manufacturers of America CEO Alan Holmer. The Louisiana congressman chairs the Energy & Commerce Committee, one of the committees responsible for shepherding the recently enacted Medicare prescription drug legislation through Congress. Holmer announced his plan to retire Jan. 15 (1"The Pink Sheet" Jan. 19, 2004, p. 17)...
You may also be interested in...
Rep. Tauzin Ready To Negotiate With PhRMA After Resigning Committee Chair
Rep. Billy Tauzin's resignation from the chairmanship of the Energy & Commerce Committee paves the way for negotiations to begin in earnest for him to take over as president of the Pharmaceutical Research & Manufacturers of America
PhRMA CEO Search Will Take Several Months; Holmer Leaving On High Note
The Pharmaceutical Research & Manufacturers of America hopes to identify a successor to President Alan Holmer within the next several months
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.